Drug Use Investigation for LAMICTAL

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Epilepsy

Treatments: Drug: Lamotrigine

Study type: Observational

Funder types: Industry

Identifiers

NCT01376180

112727

Details and patient eligibility

About

The purpose of this study is to grasp actual status of usage of lamotrigine tablet and to collect information for using lamotrigine tablet effectively and safely as well as to grasp onset status of adverse events in pediatric subjects, geriatric subjects, pregnant women, subjects with poor renal and hepatic functions.

Enrollment: 3,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with epilepsy having the following seizure types.
• Partial seizures (including secondary generalized seizures)
• Tonic-clonic seizures
• Generalized seizures of Lennox-Gastaut syndrome

Exclusion criteria

• None

Trial design

3,000 participants in 1 patient group

Subjects prescribed lamotrigine tablet

Description:

Subjects with epilepsy prescribed lamotrigine tablet during study period

Treatment:

Drug: Lamotrigine